Collectively, our findings indicate that NCSTN promotes HCC cell growth and metastasis through β-catenin activation in a Notch1/AKT dependent manner, and may be characterized as a promising target for HCC therapeutic strategies. The gene discussed is AKT1; the disease is hepatocellular carcinoma.